ask="71.20"
ask_size="100"
average_daily_volume="965168"
bid="47.52"
bid_size="300"
book_value="10.71"
change="-0.76"
change_from_200_day_moving_average="2.37"
change_from_50_day_moving_average="6.82"
change_from_52_week_high="-28.63"
change_From_52_week_low="20.10"
change_in_percent="-1.45%"
close="51.48"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-4.79"
ebitda="-409.46M"
eps_estimate_current_year="-5.08"
eps_estimate_next_quarter="-1.31"
eps_estimate_next_year="-4.67"
ex_dividend_date="N/A"
float_shares="71077000"
high="52.86"
high_52_weeks="80.11"
last_trade_date="3/9/2017"
last_trade_price="51.48"
last_trade_size="41427"
last_trade_time="4:00pm"
low="50.71"
low_52_weeks="31.38"
market_capitalization="4.43B"
moving_average_200_day="49.11"
moving_average_50_day="44.66"
name="Alnylam Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="66.40"
open="52.18"
pe_ratio="N/A"
peg_ratio="-0.22"
percent_change_from_200_day_moving_average="+4.82%"
percent_change_from_50_day_moving_average="+15.28%"
percent_change_from_52_week_high="-35.74%"
percent_change_from_52_week_low="+64.05%"
previous_close="52.24"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="4.88"
price_per_sales="95.28"
revenue="47.16M"
shares_outstanding="86013000"
short_ratio="10.31"
stock_exchange="NMS"
symbol="ALNY"
volume="811667"
weeks_range_52="31.38 - 80.11"
